• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Emtricitavine
    2 Drugs classified under this active ingredient

    All the Active Ingredient Drugs

    partial basket chart
    Multiple ingredients

    Non-Nucleoside Reverse Transcriptase Inhibitors, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors. Emtricitavine 200 mg, Rilpivirine (as HCl) 25 mg, Tenofovir Disoproxil (as Fumarate) 245 mg.
    F.C. TABS: 30. Adults: 1 tab dly with
    meal. Under 18 yrs: Not recommend.
    Over 65 yrs: use with caution. Not
    recommend. in pts. with CLcr < 50 ml/
    min. See lit.
    Comb. of emtricitabine, tenofovir
    disoproxil fumarate and rilpivirine for use
    as a complete regimen for the tmt of HIV-1
    infect. in adult pts with no antiretrov. tmt
    hist. and with HIV-1 RNA less than or equal
    to 100,000 copies/mL at the start of ther.,
    and in certain virologic. suppress. (HIV-1
    RNA <50 copies/mL) adult pts on a stable
    antiretrov. regimen at start of ther. in order
    to replace their curr. antiretrov. tmt
    C/I: Hypersens. to act. subst. or to any
    excip., co-admin. with CYP3A induc. and
    gastric pH incr.: anticonvuls. –
    carbamazepine, oxcarbazapine,
    phenobarbital, phenytoin;
    antimycobacter. – rifampin, rifapentine;
    PPI – dexlansoprazole, esomeprazole,
    lansoprazole, omeprazole, antoprazole,
    rabeprazole; glucocorticoid systemic
    dexamethasone (more than a single
    dose); St. John’s wort (Hypericum

    partial basket chart
    Multiple ingredients

    Nucleoside Reverse Transcriptase Inhibitor. Emtricitavine 200 mg, Tenofovir Disoproxil 245 mg.
    F.C. TABS: 30. 1 tab dly with
    food. Child: Under 18 yrs. not
    In comb. with other antiretrovirals to
    treat HIV-1 infects.
    C/I: Severe ren. impair., lact.